Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-300-3
CAS number: 56-93-9
TABLE 1 Summary of Reproductive Tissue Evaluations for Male Rats in the
13-Week Gavage Study of Benzyltrimethylammonium Chloridea
* Significantly different (P<0.05) from the vehicle control
group by Dunnetts test
a Data are presented as mean ± standard error. Differences
from the vehicle control group are not significant by Dunnetts test
weights) or Dunns test (spermatid and epididymal spermatozoal
TABLE 2 Estrous Cycle Characterization for Female Rats in the 13-Week
Gavage Study of Benzyltrimethylammonium Chloridea
a Necropsy body weight and estrous cycle length data are
presented as mean ± standard error. Differences from the vehicle control
group are not significant by Dunnetts test (necropsy body weight) or
Dunns test (estrous cycle length).
b Estrous cycle was longer than 12 days or unclear in one of
c Evidence shows that females administered 25 mg/kg differ
significantly (Wilks Criterion, P<0.05) from the vehicle
control females in the relative length of time spent in the estrous
stages. Dosed females spent more time in proestrus and less time in
diestrus than the
vehicle control females.
13 -week studies, groups of 10 male and 10 female rats received
benzyltrimethylammonium chloride in deionized water by gavage at doses
of 0, 12.5, 25, 50, or 100 mg/kg, 5 days per week for 13 weeks.
Benzyltrimethylammonium chloride generally had little effect on the body
weights of rats. Final mean body weights of dosed animals were within 8%
(rats) of the control group body weights. The deaths of two female rats
administered 100 mg/kg were the result of pharmacologic effects on the
cardiovascular system. Some cholinergic effects including
chromodacryorrhea, lacrimation, salivation, pupillary constriction,
altered gait, and mild tremors were observed at nonlethal doses in rats;
these effects were accompanied by alterations in body position. No
significant target organ toxicity was observed in dosed rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
På den här webbplatsen används kakor. Syftet är att optimera din upplevelse av den.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again